Arthralgias and Myalgias Related to Quinupristin-Dalfopristin Administration
نویسندگان
چکیده
منابع مشابه
Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction.
OBJECTIVES To determine whether myalgias/arthralgias occurring in cancer patients who receive quinupristin/dalfopristin are associated with biliary tract dysfunction. METHODS We studied 56 patients with vancomycin-resistant enterococcal infections who were treated with quinupristin/dalfopristin 7.5 mg/kg every 8 h for a mean duration of 12 days (range 2-52 days). Liver function tests, includi...
متن کاملRisk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy.
STUDY OBJECTIVE To evaluate risk factors for the development of arthralgias or myalgias associated with quinupristin-dalfopristin. DESIGN Retrospective chart review and case-control analysis. SETTING An 850-bed tertiary care medical center. PATIENTS All adult and pediatric patients who had received quinupristin-dalfopristin through either a compassionate-use protocol (February 1996-Octobe...
متن کاملMyalgias and arthralgias associated with paclitaxel.
Paclitaxel-induced myalgias and arthralgias occur in a significant fraction of patients receiving therapy with this taxane, potentially impairing physical function and quality of life. Paclitaxel-induced myalgias and arthralgias are related to individual doses; associations with the cumulative dose and infusion duration are less clear. Identification of risk factors for myalgias and arthralgias...
متن کاملSuccessful administration of quinupristin/dalfopristin in the outpatient setting.
Intravenous administration of quinupristin/dalfopristin outside the hospital setting has not been reported previously. We describe 37 outpatients receiving quinupristin/dalfopristin iv for infections including osteomyelitis, bacteraemia, abscesses and cellulitis. The most frequent aetiological pathogens found were Enterococcus faecium, Staphylococcus aureus and coagulase-negative staphylococci....
متن کاملQuinupristin/Dalfopristin-induced Sweet’s Syndrome
Quinupristin/Dalfopristin is a new combination of streptogramin antibiotics designed specifically to treat clinically significant infections due to Vancomycin-resistant Enterococcus Faecium. Sweet's syndrome is characterized by painful skin plaques, which is associated with dermal neutrophilic infiltration, fever and peripheral blood leukocytosis. Drug-induced Sweet's syndrome has a temporal re...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2001
ISSN: 1058-4838,1537-6591
DOI: 10.1086/318702